Extracellular Vesicle-Mediated U1 snRNA Delivery Restores Aberrant Pre-mRNA Splicing in Human Cells
Biomolecules · 2026
DOI: 10.3390/biom16020278 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Hatice Esenkaya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Molecular Biology, Karolinska Institutet, 17 177 Stockholm, Sweden. Hauptthemen laut MEDLINE: RNA, Small Nuclear, RNA Splicing, RNA Precursors, Extracellular Vesicles. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Splicing defects represent a significant class of human genetic disorders, yet strategies to directly correct aberrant splice-site recognition remain limited. The small nuclear RNA (snRNA) U1 plays a critical role in pre-messenger RNA splicing by base-pairing with the conserved 5′ splice-site ‘GU’ dinucleotide. Disruption of this interaction can lead to abnormal splicing or frameshift mutations, contributing to disease pathology. Extracellular vesicles (EVs) can transport small molecules to cells for therapeutic applications. Here, U1 snRNA-overexpressing HEK293T cells were used to generate approximately 120 nm-diameter U1 snRNA-enriched EVs, whose purity and content were confirmed by exosomal marker Western blots and reverse transcription–quantitative PCR. When HeLa cells expressing a β-globin minigene bearing a β-thalassaemia-like 5′ splice-site mutation were treated with U1-snRNA-enriched EVs, they corrected up to sixty percent of normal exon–intron junction recognition in a dose-dependent manner. Recovery was abolished by heat or RNase treatment, suggesting that intact vesicular RNA cargo was essential for activity. These findings provide the first demonstration that EVs can transport spliceosomal snRNAs capable of reconstituting splice-site recognition in recipient cells and introduce a novel class of RNA-based therapeutics that exploit the natural cargo-shuttling capacity of EVs to correct splicing defects associated with genetic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell and Molecular Biology, Karolinska Institutet, 17 177 Stockholm, Sweden.
- School of Life Sciences, Molecular Biology and Genetics, Kilis 7 Aralik University, 79000 Kilis, Turkey.
- Department of Biology, Faculty of Science, Dokuz Eylul University, 35390 Izmir, Turkey.
- School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.
ORCID-Profile: Hatice Esenkaya, Joe Bryant
Zitieren
APA
Esenkaya, H., Karaman, M., & Bryant, J. (2026). Extracellular Vesicle-Mediated U1 snRNA Delivery Restores Aberrant Pre-mRNA Splicing in Human Cells. Biomolecules. https://doi.org/10.3390/biom16020278
Vancouver
Esenkaya H, Karaman M, Bryant J. Extracellular Vesicle-Mediated U1 snRNA Delivery Restores Aberrant Pre-mRNA Splicing in Human Cells. Biomolecules. 2026. doi:10.3390/biom16020278
BibTeX
@article{Esenkaya2026,
author = {Esenkaya, Hatice and Karaman, Muhammet and Bryant, Joe},
title = {Extracellular Vesicle-Mediated U1 snRNA Delivery Restores Aberrant Pre-mRNA Splicing in Human Cells},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16020278}
}
EUVIMED